New Cancer Drug Shows Fewer Side Effects - Yahoo! News (AP)
So the osteoporosis medicine Raloxifene is giving the estrogen-blocker Tamoxifen some competition in the battle against breast cancer, according to an announcement by the National Cancer Institute today.
Interesting.
Monday, April 17, 2006
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment